---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-114042"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2026-10-06T20:05:29+00:00"
generated_at: "2026-10-12T16:22:00.802408+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# TELA Bio regains Nasdaq minimum bid price compliance; listing matter closed

## Summary
- Nasdaq letter dated October 5, 2026 states TELA Bio regained compliance with Nasdaq Listing Rule 5450(a)(1), the minimum bid price requirement for the Nasdaq Global Market; matter is now closed.
- Company's common stock continues to be listed and traded on the Nasdaq Global Market under the symbol 'TELA'.
- Filing signed by Heather Getz, Chief Executive Officer and Director, dated October 6, 2026.

## SEC filing metadata
- accession: 0001104659-26-114042
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2026-10-06T20:05:29+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465926114042/0001104659-26-114042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465926114042/tm2627116d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-114042
- JSON: https://secwatch.observer/filing/0001104659-26-114042.json
- Plain text: https://secwatch.observer/filing/0001104659-26-114042.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.